Conditions:   Primary Cutaneous Anaplastic Large Cell Lymphoma,;   Mycosis Fungoides
Interventions:   Drug: Brentuximab Vedotin;   Drug: Methotrexate or Bexarotene
Sponsors:   Millennium Pharmaceuticals, Inc.;   Millennium Pharmaceuticals, Inc.;   Seattle Genetics, Inc.
Recruiting - verified May 2012

Conditions:   Solid Tumors;   Lymphoma;   Multiple Myeloma
Intervention:   Drug: CS-7017 and Bexarotene
Sponsors:   Georgetown University;   Georgetown University;   Daiichi Sankyo Inc.
Recruiting - verified December 2011

Conditions:   Cutaneous T-cell Lymphoma;   Mycosis Fungoides;   Sezary Syndrome;   Primary Cutaneous Anaplastic Large Cell Lymphoma
Interventions:   Drug: Pralatrexate Injection;   Drug: Bexarotene Capsules;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic Acid
Sponsors:   Allos Therapeutics;   Allos Therapeutics
Recruiting - verified January 2012

Condition:   Refractory Cutaneous T-cell Lymphoma
Interventions:   Drug: bexarotene;   Drug: bexarotene
Sponsors:   Eisai Inc.;   Eisai Inc.
Recruiting - verified January 2012

Condition:   Leukemia, Myeloid, Acute
Interventions:   Drug: Decitabine and Bexarotene;   Drug: Decitabine and Bexarotene;   Drug: Decitabine and Bexarotene
Sponsors:   Washington University School of Medicine;   Washington University School of Medicine
Recruiting - verified October 2011

Conditions:   Stage I Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage I Mycosis Fungoides/Sezary Syndrome;   Stage II Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage II Mycosis Fungoides/Sezary Syndrome;   Stage III Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage III Mycosis Fungoides/Sezary Syndrome;   Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage IV Mycosis Fungoides/Sezary Syndrome
Interventions:   Drug: vorinostat;   Other: flow cytometry;   Other: laboratory biomarker analysis
Sponsors:   Fred Hutchinson Cancer Research Center;   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)
Recruiting - verified January 2012

Condition:   Acute Myeloid Leukemia
Intervention:   Drug: Bexarotene
Sponsors:   University of Pennsylvania;   University of Pennsylvania
Recruiting - verified December 2011